| Nov 15 |
European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department
|
| Nov 15 |
EMA’s CHMP recommends Sanofi’s Sarclisa approval for multiple myeloma
|
| Nov 15 |
Drugmaker stocks slide as Trump picks vaccine sceptic RFK Jr for US health job
|
| Nov 15 |
Press Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria
|
| Nov 15 |
Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU)
|
| Nov 15 |
Viking Fund Management Sells Big Oil Stocks In Q3, Cuts Tesla Position In Half, Adds To Largest Position Broadcom
|
| Nov 14 |
Vaccine makers close lower amid reports RFK Jr may head HHS (update)
|
| Nov 14 |
Press Release: Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myeloma
|
| Nov 13 |
Top Analyst Reports for UnitedHealth, Bank of America & SAP
|
| Nov 13 |
Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease
|
